A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The primary purpose of this study is to evaluate the safety profile and tolerability of single oral doses of BMS-650032 in subjects with chronic hepatitis C infection
Epistemonikos ID: cda310e79d31f12cee89a2c88ce840e1adf964f2
First added on: Mar 23, 2020